TY - JOUR ID - 69152 TI - Nanoparticles in Vaccine Development JO - Journal of Applied Biotechnology Reports JA - JABR LA - en SN - 2322-1186 AU - Hajizade, Abbas AU - Ebrahimi, Firouz AU - Salmanian, Ali-Hatef AU - Arpanaei, Ayyoob AU - Amani, Jafar AD - Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran AD - Department of Biology, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran AD - Department of Plant biotechnology, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran AD - Department of Industrial and Environmental Bio-technology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran AD - Applied Microbiology Research Centre, Baqiyatallah University of Medical Sciences, Tehran, Iran Y1 - 2014 PY - 2014 VL - 1 IS - 4 SP - 125 EP - 134 KW - Nanovaccines KW - Vaccine development KW - Nanoparticles KW - Vaccine Delivery DO - N2 - Vaccination has greatly improved human health. Despite of all improvements in this field, there is not an efficient vaccine for many diseases, and of the available ones, some could not produce a long-term immunity. Recently, there have been many researches on the applicability of nanostructures as an efficient system for vaccine delivery, and the initial results have been promising. Their potential adjuvanticity, capability of the stimulation of both humoral and cellular immunity responses, more stability in environmental conditions, possible targeted vaccine delivery, the need for low quantity of proteins (in the case of subunit vaccines), etc., are of the main reasons that this area has gained many interests. Here, we try to review the main nanostructures that could be act as a delivery vehicle in vaccine delivery. UR - https://www.biotechrep.ir/article_69152.html L1 - https://www.biotechrep.ir/article_69152_b82403be48199bee03ff60f4c68c80a2.pdf ER -